Bay City Capital — 2014 Investments

2 investments dated 2014 · listed companies and verified rows first · show all

Civitas Therapeuticscivitastherapeutics.comSeries B · Aug 2014 · $38M

BiotechChelsea, US

RICHARD BATYCKY(Executive Officer)GLENN BATCHELDER(Director)BRYAN STUART(Executive Officer)inMARK IWICKI(Executive Officer, Director)inMARTIN FREED(Executive Officer)in

BoardROB HOPFNER(Director)in

Co-investorsCanaan Partners Longitude Capital Sofinnova Ventures Fountain Healthcare Partners OrbiMed RA Capital

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Hyperion Therapeutics

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.